Home › Idiopathic Pulmonary Fibrosis › Missouri
Pag-aaral pangklinika para sa Idiopathic Pulmonary Fibrosis sa Missouri
6 pag-aaral para sa Idiopathic Pulmonary Fibrosis ang naghahanap ng mga kalahok sa mga site sa Missouri.
Opisyal na teksto ng pag-aaral (English)
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Hannibal Regional Healthcare System, Inc., Hannibal
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06951217A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Hannibal Regional Healthcare System, Inc., Hannibal
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07516951Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Hannibal Regional Hospital, Hannibal
Nagre-recruitPhase 3
Edad 40 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- The Lung Research Center, LLC, Chesterfield
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06968845Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- Hannibal Regional Hospital /ID# 277984, Hannibal
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07230288Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Washington University, St Louis
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT01915511Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.